Rx Only
Single Use
For Topical Dermatological use only.

C E
0 1 2 3

keragelT® is a keratin enriched gel category dressing utilizing keratin technology to create and maintain a moist wound environment. It is presented sterile in a tube for ease of application.

keragelT® is designed for acute/chronic superficial and partial thickness wounds with dry to medium exudate, such as:

• Venous leg ulcers
• Arterial ulcers
• Diabetic foot ulcers
• Pressure ulcers
• Skin graft donor sites
• Sunburns
• First and Second Degree burns

If the wound is infected, it is advised that you consult with your physician or health care professional.

1. Cleanse and debride the wound in accordance with normal procedures.
2. Ensure that the skin surrounding the wound is dry.
3. The tube is opened using the piercer cap to break the nozzle seal.
   To ensure sterility, sanitise the piercer cap before using.
4. Apply a 3mm to 6mm (1/8inch to 1/4inch) layer of keragelT® to cover the entire wound surface daily or three times a day as indicated by a healthcare professional.
5. Cover with an appropriate secondary dressing if needed.

The wound should be inspected daily or as indicated by a physician. For wounds that appear dry more gel should be applied to the area.

Keratin, phenoxyethanol, hydroxyethylcellulose, glycerol, sorbitol, propylene glycol, lactic acid.

Manufactured for: Molecular Biologicals, LLC
Pasadena, TX 77505 | 1-844-793-9933

Keraplast Research Limited, Gerald St., Lincoln 7674, NZ
Medical Device Consultancy, 7 Pinewood Drive, Ashley Heath,
Market Drayton, Shropshire TF9 4PA, United Kingdom

keragelT® is a registered trademark of
Keraplast Technologies LLC.
The product incorporates patented and/or patent pending
technologies owned by Keraplast Technologies LLC.

Issue Date 9/2017
DWG107/1

keragelT®

10 x
NDC 71474-302-10
20g/0.7oz

Rx Only

MOLECULAR
BIOLOGICALS

replicine™